1. Home
  2. WDFC vs CRSP Comparison

WDFC vs CRSP Comparison

Compare WDFC & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WDFC
  • CRSP
  • Stock Information
  • Founded
  • WDFC 1953
  • CRSP 2013
  • Country
  • WDFC United States
  • CRSP Switzerland
  • Employees
  • WDFC 644
  • CRSP N/A
  • Industry
  • WDFC Major Chemicals
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WDFC Industrials
  • CRSP Health Care
  • Exchange
  • WDFC Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • WDFC 3.1B
  • CRSP 3.4B
  • IPO Year
  • WDFC N/A
  • CRSP 2016
  • Fundamental
  • Price
  • WDFC $229.08
  • CRSP $47.87
  • Analyst Decision
  • WDFC Buy
  • CRSP Buy
  • Analyst Count
  • WDFC 2
  • CRSP 21
  • Target Price
  • WDFC $301.00
  • CRSP $75.42
  • AVG Volume (30 Days)
  • WDFC 78.9K
  • CRSP 2.7M
  • Earning Date
  • WDFC 04-08-2025
  • CRSP 02-11-2025
  • Dividend Yield
  • WDFC 1.63%
  • CRSP N/A
  • EPS Growth
  • WDFC 2.55
  • CRSP N/A
  • EPS
  • WDFC 5.22
  • CRSP N/A
  • Revenue
  • WDFC $603,636,000.00
  • CRSP $37,314,000.00
  • Revenue This Year
  • WDFC $8.31
  • CRSP $227.76
  • Revenue Next Year
  • WDFC $6.86
  • CRSP $353.05
  • P/E Ratio
  • WDFC $44.15
  • CRSP N/A
  • Revenue Growth
  • WDFC 9.20
  • CRSP N/A
  • 52 Week Low
  • WDFC $211.03
  • CRSP $36.52
  • 52 Week High
  • WDFC $292.36
  • CRSP $90.62
  • Technical
  • Relative Strength Index (RSI)
  • WDFC 39.96
  • CRSP 58.27
  • Support Level
  • WDFC $226.73
  • CRSP $38.28
  • Resistance Level
  • WDFC $233.88
  • CRSP $55.88
  • Average True Range (ATR)
  • WDFC 4.80
  • CRSP 2.87
  • MACD
  • WDFC 0.21
  • CRSP 1.07
  • Stochastic Oscillator
  • WDFC 15.78
  • CRSP 54.50

About WDFC WD-40 Company

WD-40 Co manufactures and sells lubricants and cleaning products. The firm's product categories include maintenance and cleaning products. Maintenance products include the WD-40 signature brand aerosol spray lubricant as well as degreasers, rust removers, and bicycle maintenance products. Cleaning products include toilet cleaners, carpet stain removers and deodorizers, and heavy-duty hand soaps used to clean grease. The company organizes itself into three segments based on geography: Americas, Europe/Middle East/Africa, and Asia-Pacific. The majority of the company's revenue comes from the Americas segment, which includes the United States, Canada, and Latin America.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: